By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.

In a challenging market environment, Adverum Biotechnologies Inc. (NASDAQ:ADVM) stock has reached a 52-week low, dipping to $4.01. The biotechnology firm, which specializes in gene therapy targeting ...

Potent in vivo gene editing in skeletal muscle of non-human primates by a novel, ultracompact CRISPR system delivered via a single AAV vector.

An interview with Glenn Saxe, computational psychiatrist, on the limitations of our current diagnostic system, and how causal ...